Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.
The Astana Times

Kazakhstan Advances in Nuclear Medicine

Nuclear medicine is entering a new stage of development in Kazakhstan. Modern technologies now make it possible to detect dangerous diseases at an early stage and improve the treatment effectiveness, ...
Chennaionline

Iswarya Hospital Opens Advanced Cancer Centre in Chennai

With the launch of the Iswarya Cancer Centre in OMR Taramani, the hospital strengthens its mission of delivering timely ...
HapaKenya

Gertrude’s Hospital warns of funding as thousands of children miss life-saving cancer care

Gertrude’s Hospital marks Kes 63M raised for cancer care but warns of a funding gap as 80% of Kenyan kids with cancer still lack treatment.

[Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Repor…

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...